IBEX Response to COVID-19

As an Essential Supplier of reagents and components for critical care diagnostics, IBEX remains operational to support the needs of its customers.

We are doing so while attending to the safety and well-being of our employees.

IBEX Technologies is a Montreal based company that manufactures and markets reagents for biomedical use through its wholly owned subsidiary IBEX Pharmaceuticals Inc.

The company’s product line comprises high purity enzymes for in-vitro diagnostics and research, as well ELISA kits for osteoarthritis research.

IBEX also provides custom production services to the major players in the in-vitro diagnostic market, including custom fermentation as well as filling and lyophilization for disposable diagnostic components.

The IBEX Pharmaceutical’s Quality Management System is certified ISO 13485:2016.

IBEX has been operational in Montreal since 1987.

droplet-325

GAG Enzymes are now available as Lyophilized Powder